Submitted by Anonymous (not verified) on 10 November 2023 - 12:14 Summary of opinion: Rystiggo,Rozanolixizumab, 09/11/2023, Positive Link: https://www.ema.europa.eu/en/medicines/human/summaries-opinion/rystiggoSource: What's new